HER2-Positive Breast Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020–2030

  • Single User License $3500

HER2-Positive Breast Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020–2030

Status : May, 2021 | Pharmaceutical

Report Digest


HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. According to International Agency for Research on Cancer (IARC) published by the World Health Organization (WHO) in 2018, approximately 627,000 deaths every year. The incidence of nmCRPC in the United States is about 50,000–60,000 cases per year. Moreover, human epidermal growth factor receptor helps breast divide, cells grow, and repair. Due to mutation in the HER2 gene that controls the HER2 protein creates too many of these receptors. As a result, breast cells grow and divide uncontrollably. About 1 of 5 of breast cancers are HER2-positive. HER2-positive breast cancer can be detected by IHC test, FISH test, biopsy, CT-scan.

Due global pandemic covid-19 disease short term lockdown impose in various regions will have short term negative impact on HER2-positive breast cancer market growth rate. Decrease in diagnosis and treatment rate caused serious impact on demand of the diagnostic test, and hospital follow up may delay the growth of HER2-positive breast cancer market. Economy collapse in key regions directly impact on healthcare spending which resulting in a steady growth rate of HER2-positive breast cancer market.

HER2-positive breast cancer market: Drivers and restraints

The rising incidence and growing prevalence of breast cancer in women will fuel the HER2-positive breast cancer market growth. Also there are many drugs in pipeline for the treatment of HER2-positive breast cancer and for treatment of breast cancer in general. While the restraints in HER2-positive breast cancer treatment market is chemotherapy and its side effects. There is a threat of reoccurrence of the tumors in majority of treatments as well as combinational therapy which is expensive and stressful for the patient.

Investment in research of cancer is growing in the US. Collaboration between Pharmaceutical companies and research institute to develop novel therapeutic and diagnostic developments. For women welfare Government taking initiative and organize cancer screening program which also fuel growth of the HER2-positive breast cancer market. Rising prevalence of cancer in developed and lower economic regions of the world can contribute towards the growth of the HER2-positive breast cancer market.

HER2-positive breast cancer has a Potential for new treatments under development and many are currently being tested. This is the major factor contributing to its market growth. Increase in prevalence rate of HER2-positive breast cancer combined to other clinical manifestations can drive the growth of the market.

Higher rate of HER2-positive breast cancer patients and demand for treatment of cancer is a major driving factor for HER2-positive breast cancer market. Moreover costly therapies hormonal therapy, chemotherapy, radiotherapy and especially genetic screening and can be a major setback the HER2-positive breast cancer market growth. Lower adaption of cancer therapy such as Hormonal Therapy, Chemotherapy in developing economic regions.

HER2-positive breast cancer market: Segmentation

The global market for HER2-positive breast cancer is segmented based on the Treatment Type, Diagnostic Test, end users

Based on Therapy Type, HER2-positive breast cancer market is segmented into following;

  • Grifola Frondosa
  • Surgery
  • Radiation and Chemotherapy
  • Endocrine Therapy
  • Molecular Targeted Therapy

 Based on Diagnostic Test, global HER2-positive breast cancer market is segmented into following:

  • IHC test
  • FISH test
  • Biopsy

 Based on distribution channels, global HER2-positive breast cancer market is segmented into following

  • Hospital
  • Specialist Clinic
  • Ambulatory Surgical Centers

HER2-positive breast cancer market: Overview

The HER2-positive breast cancer is expected to see a growth in the coming years. This is because of wide treatment portfolio, ongoing research studies and increasing awareness about breast Cancer. Rising cancer research using clinical oncology molecular diagnostic is expected to create a conducive atmosphere for the growth of the market in the near future. Recently, Clinical Oncology Molecular Diagnostic test has been applied for the development of cancer biomarkers and immunotherapies. Therefore, the increasing prevalence of cancer is expected to drive the growth of the HER2-positive breast cancer market.

HER2-positive breast cancer market: Region wise outlook

North America dominates the HER2-positive breast cancer market due to availability of more number of hospitals and clinics and higher incidences of HER2-positive breast cancer are in U.S. Specifically U.S. registered for the largest revenue shares in global HER2-positive breast cancer treatment market followed by Europe and Asia-Pacific. In Europe, holds the second largest share in the HER2-positive breast cancer treatment market due to awareness about HER2-positive breast cancer in the region. Asia Pacific and Middle East & Africa is expected to hold lucrative market share in global HER2-positive breast cancer treatment market. In recent years, there has been considerable interest in Clinical Molecular Diagnostic for cancer. Therefore, various clinical development programs in several countries are aimed at increasing HER2-positive breast cancer screening program with the help of the government.

HER2-positive breast cancer market: Key market players

Some of the key market players in HER2-positive breast cancer market are Pfizer (Pharmacia and Upjohn Company), Novartis, AstraZeneca Pharmaceuticals, Eli Lilly, Roche Group, Merck, Jiangsu HengRui Medicine, Odonate Therapeutics, Radius Pharmaceuticals, Immunomedics, Syndax Pharmaceuticals, Bayer, Eagle Pharmaceuticals, Merrimack Pharmaceuticals, GlaxoSmithKline and Millennium Pharmaceuticals.

The research report on HER2-positive breast cancer presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on HER2-positive breast cancer provides analysis and information according to market segments such as geographies, application, and industry.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?